Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells
Wanich Suksatan, Supat Chupradit, Alexei Valerievich Yumashev, Ravula Sahithya Ravali, Mohammed Nader Shalaby, Yasser Fakri Mustafa, Anatoley Kurochkin, Homayoon Siahmansouri
Topics & Concepts
Mesenchymal stem cellMedicineImmunologyImmune systemInflammationCoronavirusStem cellImmunosuppressionMicrovesiclesCell therapyDiseaseCoronavirus disease 2019 (COVID-19)BiologyPathologyInfectious disease (medical specialty)microRNABiochemistryGeneGeneticsKawasaki Disease and Coronary ComplicationsInflammasome and immune disordersCOVID-19 Clinical Research Studies